EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China

Hongxiang Ji, Hualin Sun, Yinghui Zhang, Ziyi Zhao, Xin Gao, Chunhe Wang, Yang Yang, Xiaodong Zhang, Jianyong Gao, Dequan Man, Qian Yang, Ying Yang und 4 weitere

Frontiers in Cardiovascular Medicine · 12.11.2024 · 11

DOI: 10.3389/fcvm.2024.1391282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 12.11.2024. Verfasst von Hongxiang Ji und 15 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the real-life effectiveness and safety of hydrogen inhalation (HI) therapy as an additional treatment in Chinese adults with hypertension.

Methods

This observational, retrospective clinical study included hypertensive patients receiving routine antihypertensives with or without HI initiation from 2018 to 2023. Participants were assigned to the HI group or non-HI group (control group) after propensity score matching. The changes in mean systolic blood pressure (SBP) level during the 24-week follow-up period in different groups were examined primarily. The secondary outcome was the changes in diastolic blood pressure (DBP) and blood pressure (BP) control rate during the study. Several subgroup and sensitivity analyses were performed to confirm the robustness of our main findings. Adverse event (AE) was also assessed in patients of both groups.

Results

In total, we selected 2,364 patients into the analysis. Both mean SBP and DBP levels significantly decreased in the HI group compared to control group at each follow-up visit with the between group difference of −4.63 mm Hg (95% CI, −6.51 to −2.74) at week 8, −6.69 mm Hg (95% CI, −8.54 to −4.85) at week 16, −7.81 mm Hg (95% CI, −9.57 to −6.04) at week 24 for SBP, and −1.83 mm Hg (95% CI, −3.21 to −0.45) at week 8, −2.57 mm Hg (95% CI, −3.97 to −1.17) at week 16, −2.89 mm Hg (95% CI, −4.24 to −1.54) at week 24 for DBP. Patients in the HI group were more likely to attain controlled BP at the follow-up period with odds ratio of 1.44 (95% CI, 1.21–1.72) at week 8, 1.90 (95% CI, 1.59–2.27) at week 16, and 2.24 (95% CI, 1.87–2.68) at the end. The trends of subgroup and sensitivity analyses were mostly consistent with the main analysis. The incidences of AEs were similar between the HI group and control group with all p -value >0.05.

Conclusion

The HI therapy is related to significant amelioration in BP levels with acceptable safety profile in Chinese hypertensive adults after 24 weeks of treatment, building a clinical ground for further research to evaluate the antihypertensive effect of HI therapy.

Schlagwörter

Stichwörter der Autor:innen

blood pressurehydrogen inhalationhypertensionobservational studyreal-world study

Autor:innen und Institutionen

  • The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Graduate School, Chengde Medical University, Chengde, Hebei, China.
  • Nursing Department, Qingzhou People's Hospital, Qingzhou, Shandong, China.
  • Department of Hand and Foot, Microsurgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • School of Health Management, Hengxing University, Qingdao, Shandong, China.
  • Center of Integrated Traditional Chinese and Western Medicine, School of Basic Medicine, Qingdao University, Qingdao, Shandong, China.

Zitieren

APA

Ji, H., Sun, H., Zhang, Y., Zhao, Z., Gao, X., Wang, C., Yang, Y., Zhang, X., Gao, J., Man, D., Yang, Q., Yang, Y., Yue, C., Chen, C., Ding, X., & Ni, T. (2024). Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1391282

Vancouver

Ji H, Sun H, Zhang Y, Zhao Z, Gao X, Wang C, et al. Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1391282

BibTeX
@article{Ji2024,
  author = {Ji, Hongxiang and Sun, Hualin and Zhang, Yinghui and Zhao, Ziyi and Gao, Xin and Wang, Chunhe and Yang, Yang and Zhang, Xiaodong and Gao, Jianyong and Man, Dequan and Yang, Qian and Yang, Ying and Yue, Chengbin and Chen, Changjiang and Ding, Xiaoheng and Ni, Tongshang},
  title = {Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2024},
  volume = {11},
  doi = {10.3389/fcvm.2024.1391282}
}
Kostenlos starten →